{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:13:59Z","timestamp":1789150439705,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T00:00:00Z","timestamp":1768694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T00:00:00Z","timestamp":1768694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-025-04215-2","type":"journal-article","created":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T17:56:22Z","timestamp":1768758982000},"page":"2864-2875","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimizing limited antibody panels for efficient hematological disorders diagnosis by flow cytometry in resource-constrained setting"],"prefix":"10.1007","volume":"28","author":[{"given":"Yasar","family":"Yousafzai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9117-6228","authenticated-orcid":false,"given":"Awal","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehreen","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadiq Noor","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Mushtaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mujahid","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,18]]},"reference":[{"issue":"2","key":"4215_CR1","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/bjh.15463","volume":"182","author":"BJ Bain","year":"2018","unstructured":"Bain BJ. Multiparameter flow cytometry in the diagnosis of hematologic malignancies A. Porwit and M. C. B\u00e9n\u00e9 (eds), Cambridge University Press, Cambridge, 2018, ISBN 978-1-107-50383-0. Br J Haematol. 2018;182(2):308\u2013308. https:\/\/doi.org\/10.1111\/bjh.15463.","journal-title":"Br J Haematol"},{"issue":"2","key":"4215_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.4168\/aair.2020.12.2.292","volume":"12","author":"WK Kwon","year":"2020","unstructured":"Kwon WK, Choi SI, Kim HJ, Huh HJ, Kang JM, Kim YJ, et al. Flow cytometry for the diagnosis of primary immunodeficiency diseases: a single-center experience. Allergy Asthma Immunol Res. 2020;12(2):292\u2013305. https:\/\/doi.org\/10.4168\/aair.2020.12.2.292.","journal-title":"Allergy Asthma Immunol Res"},{"issue":"2","key":"4215_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13223-018-0290-5","volume":"14","author":"C McCusker","year":"2018","unstructured":"McCusker C, Upton J, Warrington R. Primary immunodeficiency disease. Allergy Asthma Clin Immunol. 2018;14(2):1\u201312. https:\/\/doi.org\/10.1186\/S13223-018-0290-5.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"4215_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2017.01925","volume":"0","author":"L Pastor","year":"2018","unstructured":"Pastor L, Urrea V, Carrillo J, Parker E, Fuente-Soro L, Jairoce C, et al. Dynamics of CD4 and CD8 T-cell subsets and inflammatory biomarkers during early and chronic HIV infection in Mozambican adults. Front Immunol. 2018;0:1925. https:\/\/doi.org\/10.3389\/FIMMU.2017.01925.","journal-title":"Front Immunol"},{"issue":"1","key":"4215_CR5","doi-asserted-by":"publisher","DOI":"10.4103\/AJTS.AJTS_83_18","volume":"13","author":"M Murugesan","year":"2019","unstructured":"Murugesan M, Nair CK, Nayanar SK, Pentapati KC. Flow cytometric enumeration of CD34+ hematopoietic stem cells: a comparison between single-versus dual-platform methodology using the International Society of Hematotherapy and Graft Engineering protocol. Asian J Transfus Sci. 2019;13(1):43. https:\/\/doi.org\/10.4103\/AJTS.AJTS_83_18.","journal-title":"Asian J Transfus Sci"},{"issue":"3","key":"4215_CR6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1590\/S1679-45082016AO3641","volume":"14","author":"RP Correia","year":"2016","unstructured":"Correia RP, Bento LC, Bortolucci AC, Alexandre AM, Vaz AD, Schimidell D, et al. Technical advances in flow cytometry-based diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria. Einstein (S\u00e3o Paulo). 2016;14(3):366\u201373. https:\/\/doi.org\/10.1590\/S1679-45082016AO3641.","journal-title":"Einstein (S\u00e3o Paulo)"},{"issue":"1","key":"4215_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0211130","volume":"14","author":"K Navred","year":"2019","unstructured":"Navred K, Martin M, Ekdahl L, Zetterberg E, Andersson NG, Strandberg K, et al. A simplified flow cytometric method for detection of inherited platelet disorders\u2014a comparison to the gold standard light transmission aggregometry. PLoS ONE. 2019;14(1):1\u201312. https:\/\/doi.org\/10.1371\/journal.pone.0211130.","journal-title":"PLoS ONE"},{"issue":"11","key":"4215_CR8","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/JCLINPATH-2015-203088","volume":"68","author":"GE Bignardi","year":"2015","unstructured":"Bignardi GE. Flow cytometry for the microscopy of body fluids in patients with suspected infection. J Clin Pathol. 2015;68(11):870\u20138. https:\/\/doi.org\/10.1136\/JCLINPATH-2015-203088.","journal-title":"J Clin Pathol"},{"issue":"1","key":"4215_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1309\/AJCPANA7ER1ABMZI","volume":"135","author":"FE Craig","year":"2011","unstructured":"Craig FE, Ohori NP, Gorrill TS, Swerdlow SH. Flow cytometric immunophenotyping of cerebrospinal fluid specimens. Am J Clin Pathol. 2011;135(1):22\u201334. https:\/\/doi.org\/10.1309\/AJCPANA7ER1ABMZI.","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"4215_CR10","doi-asserted-by":"publisher","DOI":"10.4103\/0970-9371.145577","volume":"31","author":"T Paul","year":"2014","unstructured":"Paul T, Gautam U, Rajwanshi A, Das A, Trehan A, Malhotra P, et al. Flow cytometric immunophenotyping and cell block immunocytochemistry in the diagnosis of primary non-Hodgkin\u2019s lymphoma by fine-needle aspiration: experience from a tertiary care center. J Cytol. 2014;31(3):123. https:\/\/doi.org\/10.4103\/0970-9371.145577.","journal-title":"J Cytol"},{"issue":"Supplement_1","key":"4215_CR11","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.1182\/blood-2019-131711","volume":"134","author":"H Wood","year":"2019","unstructured":"Wood H, Sanchez K, Potter V, Kulasekararaj A, de Lavallade H, Yallop D, et al. Post-transplant flow cytometry MRD predicts relapse in a real world AML cohort. Blood. 2019;134(Supplement_1):4566\u20134566. https:\/\/doi.org\/10.1182\/blood-2019-131711.","journal-title":"Blood"},{"key":"4215_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/S12308-014-0226-Z","author":"BL Wood","year":"2014","unstructured":"Wood BL. Flow cytometry in the diagnosis and monitoring of acute leukemia in children. J Hematop. 2014. https:\/\/doi.org\/10.1007\/S12308-014-0226-Z.","journal-title":"J Hematop"},{"issue":"Supplement_1","key":"4215_CR13","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1182\/blood-2019-123904","volume":"134","author":"A Bazinet","year":"2019","unstructured":"Bazinet A, Rys RN, Wever CM, Barry A, Greenwood C, Young C, et al. A 10-color flow cytometry panel for both diagnosis and minimal residual disease measurement in chronic lymphocytic leukemia. Blood. 2019;134(Supplement_1):5451\u20135451. https:\/\/doi.org\/10.1182\/blood-2019-123904.","journal-title":"Blood"},{"issue":"3","key":"4215_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1182\/blood-2016-07-726307","volume":"129","author":"P Theunissen","year":"2017","unstructured":"Theunissen P, Mejstrikova E, Sedek L, van der Sluijs-Gelling AJ, Gaipa G, Bartels M, et al. Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia. Blood. 2017;129(3):347\u201357. https:\/\/doi.org\/10.1182\/blood-2016-07-726307.","journal-title":"Blood"},{"issue":"1","key":"4215_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/CYTO.B.21831","volume":"98","author":"PR Tembhare","year":"2020","unstructured":"Tembhare PR, Pg PGS, Ghogale S, Chatterjee G, Patkar NV, Gupta A, et al. A high-sensitivity 10-color flow cytometric minimal residual disease assay in B-lymphoblastic leukemia\/lymphoma can easily achieve the sensitivity of 2-in-106 and is superior to standard minimal residual disease assay: a study of 622 patients. Cytom B Clin Cytom. 2020;98(1):57\u201367. https:\/\/doi.org\/10.1002\/CYTO.B.21831.","journal-title":"Cytom B Clin Cytom"},{"key":"4215_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/421906","author":"F Xu","year":"2014","unstructured":"Xu F, Yin CX, Wang CL, Jiang XJ, Jiang L, Wang ZX, et al. Immunophenotypes and immune markers associated with acute promyelocytic leukemia prognosis. Dis Mark. 2014. https:\/\/doi.org\/10.1155\/2014\/421906.","journal-title":"Dis Mark"},{"issue":"1","key":"4215_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-019-4319-8","volume":"12","author":"AA Basabaeen","year":"2019","unstructured":"Basabaeen AA, Abdelgader EA, Bahashwan OS, Babekir EA, Abdelateif NM, Bamusa SA, et al. Combined analysis of ZAP-70 and CD38 expression in sudanese patients with B-cell chronic lymphocytic leukemia. BMC Res Notes. 2019;12(1):1\u20136. https:\/\/doi.org\/10.1186\/s13104-019-4319-8.","journal-title":"BMC Res Notes"},{"key":"4215_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4557-4083-3.00017-6","author":"JA Ramos-Vara","year":"2016","unstructured":"Ramos-Vara JA, Avery PR, Avery AC. Advanced diagnostic techniques. Canine Feline Cytol. 2016. https:\/\/doi.org\/10.1016\/B978-1-4557-4083-3.00017-6.","journal-title":"Canine Feline Cytol."},{"key":"4215_CR19","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1309\/AJCP3FEPX5BEEKGX","volume":"137","author":"P McGowan","year":"2012","unstructured":"McGowan P, Nelles N, Wimmer J, Williams D, Wen J, Li M, et al. Differentiating between Burkitt lymphoma and CD10+ diffuse large B-cell lymphoma the role of commonly used flow cytometry cell markers and the application of a multiparameter scoring system. Am J Clin Pathol. 2012;137:665. https:\/\/doi.org\/10.1309\/AJCP3FEPX5BEEKGX.","journal-title":"Am J Clin Pathol"},{"key":"4215_CR20","unstructured":"Kishore M, Kumar V, Kaushal M, Ahuja A, Bhardwaj M. Early diagnosis of an aggressive childhood malignancy with flow-cytometric immunophenotyping: a case report. Ann Med Health Sci Res. www.amhsr.org\/articles\/early-diagnosis-of-an-aggressive-childhood-malignancy-with-flowcytometric-immunophenotyping-a-case-report-5142.html. Accessed 23 Oct 2021."},{"key":"4215_CR21","doi-asserted-by":"publisher","unstructured":"Kalkan R. The use of molecular cytogenetic techniques for the identification of chromosomal abnormalities. In: Chromosomal abnormalities a hallmark manifestation of genomic instability. IntechOpen; 2017. https:\/\/doi.org\/10.5772\/67415.","DOI":"10.5772\/67415"},{"issue":"22","key":"4215_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16223855","volume":"16","author":"F Ally","year":"2024","unstructured":"Ally F, Chen X. Acute myeloid leukemia: diagnosis and evaluation by flow cytometry. Cancers. 2024;16(22):3855. https:\/\/doi.org\/10.3390\/cancers16223855.","journal-title":"Cancers"},{"issue":"2","key":"4215_CR23","doi-asserted-by":"publisher","first-page":"457","DOI":"10.12669\/PJMS.342.13996","volume":"34","author":"A Shahni","year":"2018","unstructured":"Shahni A, Saud M, Siddiqui S, Mukry SN. Expression of aberrant antigens in hematological malignancies: a single center experience. Pak J Med Sci. 2018;34(2):457. https:\/\/doi.org\/10.12669\/PJMS.342.13996.","journal-title":"Pak J Med Sci"},{"issue":"1","key":"4215_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.7314\/APJCP.2014.15.1.221","volume":"15","author":"NABMMH Abdulateef","year":"2014","unstructured":"Abdulateef NABMMH. Clinical significance of co-expression of aberrant antigens in acute leukemia: a retrospective cohort study in Makah Al Mukaramah, Saudi Arabia. Asian Pac J Cancer Prev. 2014;15(1):221\u20137. https:\/\/doi.org\/10.7314\/APJCP.2014.15.1.221.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"4215_CR25","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/J.MJAFI.2016.01.002","volume":"72","author":"S Gupta","year":"2016","unstructured":"Gupta S, Chatterjee T, Sharma S, Sharma A, Ganguly P, Singh J, et al. Flowcytometric comparative analysis in acute leukemias between Indian and proposed minimal screening panel. Med J Armed Forces India. 2016;72(3):220\u201330. https:\/\/doi.org\/10.1016\/J.MJAFI.2016.01.002.","journal-title":"Med J Armed Forces India"},{"issue":"1","key":"4215_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.21141\/PJP.2021.04","volume":"6","author":"IM Medalla","year":"2021","unstructured":"Medalla IM, Gepte MB, Pido Q, Ang D. Cost-effectiveness of limited screening panel for acute lymphoblastic leukemia diagnosis in a resource-limited setting. PJP. 2021;6(1):27\u201330. https:\/\/doi.org\/10.21141\/PJP.2021.04.","journal-title":"PJP"},{"issue":"6","key":"4215_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1080\/10245332.2016.1139792","volume":"21","author":"N Singh","year":"2016","unstructured":"Singh N, Pati HPP, Tyagi S, Deka R, Sharma R, Saxena R. Proposed minimal panel of antibodies for cost-effectiveness and accuracy in acute leukemias immunophenotyping: prospective study at a tertiary care center. Hematology. 2016;21(6):338\u201342. https:\/\/doi.org\/10.1080\/10245332.2016.1139792.","journal-title":"Hematology"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04215-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-04215-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04215-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:57:58Z","timestamp":1781873878000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-04215-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,18]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["4215"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-04215-2","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,18]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"I,\u00a0Awal Mir , hereby declare that there are no conflicts of interest associated with the publication of the manuscript titled \u201cOptimizing Limited Antibody Panels for Efficient Hematological Disorders Diagnosis by Flow Cytometry in Resource-Constrained Settings\u201d. I affirm that I have read and understood the journal guidelines regarding conflict-of-interest disclosure and confirm that there is no financial or non-financial conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed according to the Declaration of Helsinki for medical research on human subjects and was approved by the Institutional Ethics Committee of the Khyber Medical University (No. DIR\/KMU-IPMS\/IEC\/approval-0079), Peshawar. Informed consent was obtained from all the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval, Research involving human participants and\/or animals and Informed consent"}}]}}